C19study.com update: Now 88 international studies (51 peer reviewed) show positive hydroxychloroquine treatment outcomes

Source: c19 Study

A live and ongoing index of study data from around the world documenting the use of hydroxychloroquine in treatment at various stages of SARS-CoV-2 infection including pre-exposure prophylaxis and post-exposure prophylaxis is available at https://c19study.com/

Overwhelmingly, PrEP, PEP, and early treatment studies show high effectiveness of hydroxychloroquine, while late treatment shows mixed results.

blank







Related:
Mortality 0%: A comprehensive strategy for the early treatment of COVID-19 with azithromycin/hydroxychloroquine and/or corticosteroids: results of a retrospective observational study in the French overseas department of Reunion Island

Hydroxychloroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients in Saudi Arabia

Twin Covid-19 patients in South Carolina: one received hydroxychloroquine, the other did not.

Hydroxychloroquine: Didier Raoult denounces the biggest scientific scandal of all time

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »